Unitil Corporation

Global Water Resources, Inc.

Sky Harbour Group Corporation

Millrose Properties, Inc.

The Fed will announce its interest-rate decision on Wednesday, October 29. Markets <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">expect</a>&nbsp;a 25-basis-point cut to 3.75-4.00%. The prior revision in September reignited the stock market, and analysts <a href="https://en.oninvest.com/article/russell-2000-is-clear-winner-from-fed-rate-cut-reaches-new-all-time-high">called</a>&nbsp;small-caps – represented by the Russell 2000 index – the “clear winner.” The day after the decision, on September 18, the index hit a new all-time high for the first time in four years, jumping 2%. Over the last six months, the <a href="https://finance.yahoo.com/quote/%5ERUT/">Russell 2000</a>&nbsp;is up 28.4%, outpacing the <a href="https://finance.yahoo.com/quote/%5ESPX/">S&amp;P 500</a>, the benchmark for large caps, which is up 23.8% in the same period.

Freedom picks small caps set to gain from another Fed rate cut

Beyond Meat, Inc.

Alector, Inc.

Freedom Broker has pointed out the two small-cap stocks with the most pronounced moves last week (October 20-24). The outperformer was plant-based meat producer Beyond Meat, while the underperformer was biopharma company Alector, a developer of therapies for dementia.

Freedom Broker names biggest small cap outperformer and underperformer from last week

Twin Hospitality Group Inc.

The fair value of shares of small-cap restaurant operator Twin Hospitality Group is $10 apiece, or 154% above <a href="https://finance.yahoo.com/quote/TWNP/">current quotes</a>, Noble Capital Markets estimates in a <a href="https://dashboard.channelchek.com/wp-content/uploads/pdf/TWNP_20251021_27732.pdf">coverage initiation report</a> on the company. The analysts say the company has considerable scope to expand, both by adding new restaurants and by tightening operations.

Noble initiates on small-cap restaurant stock Twin Hospitality with 150% upside

Investors who were betting against plant-based meat producer Beyond Meat <a href="https://www.businessinsider.com/beyond-meat-stock-short-sellers-meme-rally-retail-traders-bynd-2025-10?IR=T">lost</a>&nbsp;about $120 million in less than a week. The four-day <a href="https://en.oninvest.com/article/symbol-of-rebellion-beyond-meat-stock-rockets-466-in-two-days">rally</a>&nbsp;in the small cap sent the shares up nearly 1,400%, with Beyond Meat being called a meme stock.

Short sellers lose $120 million in a week as Beyond Meat rallies nearly 1,400%

Innodata Inc.

Is the Google partner and beneficiary of the AI boom still worth buying?

Small cap with big ambitions: Data services firm Innodata up nearly 300% in LTM

Vicor Corporation

Quotes of Vicor Corporation, which makes&nbsp;modular power components and complete power systems, jumped 30% yesterday, October 22, after the company <a href="https://vicorcorporation.gcs-web.com/news-releases/news-release-details/vicor-corporation-reports-results-third-quarter-ended-15">reported</a>&nbsp;quarterly results that <a href="https://finance.yahoo.com/news/why-vicor-stock-skyrocketed-today-211039597.html">beat</a>&nbsp;Wall Street expectations. The earnings&nbsp;<a href="https://www.barrons.com/articles/vicor-stock-ai-power-demand-290abf65?mod=RTA">prompted</a>&nbsp;several analysts to raise their recommendations on the stock.

Power-systems maker Vicor soars on strong, AI-boosted earnings and analyst upgrades

BioAge Labs, Inc.

Citigroup has upgraded to "buy" shares of small-cap obesity drug developer BioAge Labs, calling the company’s lead molecule promising, with the first-in-human study recently <a href="https://ir.bioagelabs.com/news-releases/news-release-details/bioage-labs-announces-first-participant-dosed-phase-1-clinical">announced</a>. The upgrade <a href="https://finance.yahoo.com/quote/BIOA/?guccounter=1&amp;guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&amp;guce_referrer_sig=AQAAANJzO7qhtq4ftfonGEodVUta3W7CcmJ8wkHgYAForTOSW-XBS4xlKF7KLyQk0L35CoYcX_jqygts2GD4qGMiFBIdNwS4SdNJF98C33sKbOp9lSNggPnmigup5BLKbWDPzB_A28f6kwvxv2u7wovLH2Nc3V4Qa7V3KMWqsBlp24tN">sent</a>&nbsp;the stock up more than 14%. Citigroup believes it could rise a further 70%.

Citigroup upgrades rating, TP on obesity drugmaker BioAge amid upcoming clinical data

Minerva Neurosciences, Inc.

Quotes of Minerva Neurosciences, a micro-cap developer of a drug against negative symptoms in patients with schizophrenia, <a href="https://finance.yahoo.com/quote/NERV/">soared</a>&nbsp;140% in one day. The company, which is worth just $44.8 million on the Nasdaq, <a href="https://ir.minervaneurosciences.com/news-releases/news-release-details/minerva-neurosciences-announces-financing-200-million-advance">said</a>&nbsp;it had raised up to $200 million to complete trials of its drug and will, if they prove successful, file for approval and prepare for a commercial launch.

Minerva soars 140% on up to $200 mln raise to finish schizophrenia drug trial

A short squeeze and social media campaigns by retail investors are behind it

'Symbol of rebellion': Beyond Meat stock rockets 466% in two days

NANO Nuclear Energy Inc.

Silex Systems Limited

Lightbridge Corporation

Many countries are rethinking past limits on nuclear power, given its role in meeting climate targets and bolstering energy security. In the U.S., a series of <a href="https://www.whitehouse.gov/presidential-actions/2025/05/ordering-the-reform-of-the-nuclear-regulatory-commission/#:~:text=(c)%25C2%25A0%2520Facilitate%2520the%2520expansion%2520of%2520American%2520nuclear%2520energy%2520capacity%2520from%2520approximately%2520100%2520GW%2520in%25202024%2520to%2520400%2520GW%2520by%25202050%253B">executive actions</a> in May 2025 set an explicit goal to quadruple nuclear capacity to 400 gigawatts by 2050. They direct federal agencies to strip out unnecessary red tape, accelerate licensing, and spur construction of new reactors and uranium-enrichment facilities. Washington’s aim is to revive the domestic fuel cycle and curb import reliance – note the U.S. still <a href="https://www.eia.gov/uranium/marketing/pdf/2024%20UMAR.pdf">buys</a>&nbsp;roughly 20% of its enriched uranium from Russia.

Which small caps are benefitting from surging demand for nuclear power?

Investors with a long-term horizon should take a closer look at shares of luxury home goods seller RH, <a href="https://www.fool.com/investing/2025/10/21/why-this-california-based-companys-stock-could-rew/">writes</a>&nbsp;Jeremy Bowman, an analyst at the Motley Fool. The company has faced a number of challenges, leading to a major fall in its share price since the highs reached during the pandemic. But it has several drivers of growth – from expansion into Europe to launching new businesses – that could turn things around, Bowman argues.

The Motley Fool spotlights mid-cap luxury goods retailer RH for patient investors

NeuroSense Therapeutics Ltd.

Noble Capital Markets has initiated coverage of NeuroSense Therapeutics with an “outperform” rating and a target price of $9 per share. Thus, it estimates the micro-cap developer of an amyotrophic lateral sclerosis therapy could rise 620% from current levels. The analysts cite mid-stage trial results of the company’s lead drug PrimeC, which open the way for accelerated registration and earlier commercialization.

Small caps